Loading clinical trials...
Loading clinical trials...
Primary aldosteronism (PA) is the most common endocrine cause of hypertension. 68Ga-pentixafor PET/CT possesses a relatively high sensitivity and specificity for Aldosterone producing adenoma (APA) de...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fangfang Sun
NCT04179019 · Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
NCT05927961 · Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
NCT05649631 · Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
NCT05186675 · Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
NCT03174847 · Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma, and more
First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions